Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma

Status:
Terminated

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

This research is being done to find out the safety of MORAb-028 in subjects with metastatic melanoma.

Phase 1

Morphotek